PL2869854T3 - Kompozycja do promowania regeneracji uszkodzonej tkanki ciała zawierająca ektoinę lub hydroksyektoinę jako substancję czynną - Google Patents

Kompozycja do promowania regeneracji uszkodzonej tkanki ciała zawierająca ektoinę lub hydroksyektoinę jako substancję czynną

Info

Publication number
PL2869854T3
PL2869854T3 PL13737554T PL13737554T PL2869854T3 PL 2869854 T3 PL2869854 T3 PL 2869854T3 PL 13737554 T PL13737554 T PL 13737554T PL 13737554 T PL13737554 T PL 13737554T PL 2869854 T3 PL2869854 T3 PL 2869854T3
Authority
PL
Poland
Prior art keywords
hydroxyecotine
ecotine
regeneration
promoting
composition containing
Prior art date
Application number
PL13737554T
Other languages
English (en)
Inventor
Andreas Bilstein
Olaf SCHERNER
Georg Lentzen
Original Assignee
Bitop Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitop Ag filed Critical Bitop Ag
Publication of PL2869854T3 publication Critical patent/PL2869854T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
PL13737554T 2012-07-09 2013-06-19 Kompozycja do promowania regeneracji uszkodzonej tkanki ciała zawierająca ektoinę lub hydroksyektoinę jako substancję czynną PL2869854T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102012013482.7A DE102012013482A1 (de) 2012-07-09 2012-07-09 Zusammensetzung zur Förderung der Wiederherstellung von verletztem Körpergewebe
PCT/EP2013/062708 WO2014009118A1 (de) 2012-07-09 2013-06-19 Zusammensetzung, enthaltend als wirkstoff ectoin oder hydroxyectoin zur förderung der wiederherstellung von verletztem körpergewebe
EP13737554.9A EP2869854B1 (de) 2012-07-09 2013-06-19 Zusammensetzung, enthaltend als wirkstoff ectoin oder hydroxyectoin zur förderung der wiederherstellung von verletztem körpergewebe

Publications (1)

Publication Number Publication Date
PL2869854T3 true PL2869854T3 (pl) 2019-09-30

Family

ID=48794047

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13737554T PL2869854T3 (pl) 2012-07-09 2013-06-19 Kompozycja do promowania regeneracji uszkodzonej tkanki ciała zawierająca ektoinę lub hydroksyektoinę jako substancję czynną

Country Status (11)

Country Link
US (3) US20150297592A1 (pl)
EP (3) EP3536351A1 (pl)
CN (2) CN107252427B (pl)
DE (1) DE102012013482A1 (pl)
DK (1) DK2869854T3 (pl)
ES (2) ES2734252T3 (pl)
HU (1) HUE044118T2 (pl)
PL (1) PL2869854T3 (pl)
PT (1) PT2869854T (pl)
TR (1) TR201909626T4 (pl)
WO (1) WO2014009118A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3120841A1 (de) * 2015-07-23 2017-01-25 Christophe Sivanzire Pharmazeutisches präparat
DE102015121050A1 (de) * 2015-12-03 2017-06-08 Bitop Ag Kompatibles Solut oder Solutgemisch zur Verwendung bei der Prävention oder Behandlung von Krankheiten mit Barrieredefekten in Epithelgeweben
DE102016111882A1 (de) * 2016-06-29 2018-01-04 Bitop Ag Zusammensetzung zur Bekämpfung von gastroösophagealen Refluxerkrankungen
TWI629265B (zh) * 2017-04-13 2018-07-11 元智大學 Reactive raw humectant and its preparation
US10543158B2 (en) 2017-04-17 2020-01-28 W Skincare, LLC Autophagy activating complex, compositions and methods
CN107375996B (zh) * 2017-07-31 2018-09-21 长沙海润生物技术有限公司 一种生物功能性敷料及其制备方法
CN107496661A (zh) * 2017-09-11 2017-12-22 南京华开生物科技有限公司 硅酮疤痕凝胶及其制备方法
JP6315533B1 (ja) * 2018-02-01 2018-04-25 株式会社ノエビア 皮膚外用剤
CN110732802A (zh) * 2018-10-22 2020-01-31 嘉兴学院 细间距焊盘键合用缓蚀助焊剂及其制备方法
CN109731123A (zh) * 2019-02-25 2019-05-10 湖南博隽生物医药有限公司 一种医学护理用抗感染材料及其制备方法
TWI723482B (zh) * 2019-07-31 2021-04-01 嘉會生技股份有限公司 促進富含血小板血漿釋放生長因子之方法
CN110575403A (zh) * 2019-10-25 2019-12-17 深圳市阳光优品科技有限公司 一种可减少防晒乳中的化学防晒剂添加量的制备方法
CN110859775A (zh) * 2019-12-03 2020-03-06 中国科学院青岛生物能源与过程研究所 甘油葡萄糖苷在透皮吸收组合物中的应用
CN111172127A (zh) * 2020-01-17 2020-05-19 浙江工业大学 一种蔗糖磷酸化酶在制备甘油葡萄糖苷中的应用
CN111773222A (zh) * 2020-08-10 2020-10-16 华熙生物科技股份有限公司 四氢嘧啶和/或羟基四氢嘧啶在制备治疗烧烫伤药物中的应用
CN112107720A (zh) * 2020-09-18 2020-12-22 华熙生物科技股份有限公司 透气性好的医用压敏胶及依克多因在提高医用压敏胶透气性中的应用
CN115192602B (zh) * 2021-04-14 2024-02-02 华熙生物科技股份有限公司 一种复合益生元及其在调节肠道功能中的应用
GR20220100433A (el) * 2022-05-24 2023-12-11 Θεοδοσιος Ιωαννη Λαζαρελης Φυσικο προϊον για την υγεια της περι-πρωκτικης περιοχης

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19540749A1 (de) 1995-11-02 1997-05-07 Beiersdorf Ag Kosmetische Zubereitungen mit einem wirksamen Gehalt an Glycosylglyceriden
US6242010B1 (en) * 1999-07-21 2001-06-05 Thione International, Inc. Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions
DE10006578C2 (de) 2000-02-14 2002-10-31 Bitop Ag Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren
ITMI20020404A1 (it) * 2002-02-28 2003-08-28 Ist Naz Stud Cura Dei Tumori Nuova manganese superossido dismutasi umana
DE10317400B4 (de) 2003-04-15 2006-04-13 Universitätsklinikum Hamburg-Eppendorf EX-VIVO-Hautorganmodell aus Schweinehaut
JP2004331579A (ja) * 2003-05-08 2004-11-25 Noevir Co Ltd 真皮マトリックス産生促進剤
DE10330243A1 (de) 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
AT504347B8 (de) * 2006-09-21 2008-09-15 Univ Graz Tech Verfahren zur herstellung von glucosederivaten
DE102006056766A1 (de) 2006-12-01 2008-06-05 Bitop Ag Verwendung von kompatiblen Soluten
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
DE102008039231A1 (de) * 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
DE102008053549A1 (de) * 2008-10-28 2010-04-29 Bitop Ag Glucosylglycerol enthaltende Zusammensetzung
JP2009161564A (ja) * 2009-04-23 2009-07-23 Tokiwa Yakuhin Kogyo Kk アトピー性皮膚炎治療用組成物
WO2011141611A1 (es) * 2010-05-14 2011-11-17 Sanidad Y Residencias 21, S.A., Composiciones de oleuropeína para cicatrización de heridas y úlceras en ancianos y/o diabéticos
CN102247374B (zh) * 2011-04-22 2013-05-22 山东弘立医学动物实验研究有限公司 含有四氢嘧啶及其衍生物的治疗皮肤创伤的药物
CN102357097A (zh) * 2011-09-01 2012-02-22 朱道辰 一种预防和治疗皮肤冻伤的药物

Also Published As

Publication number Publication date
EP2869854B1 (de) 2019-04-10
EP2869854A1 (de) 2015-05-13
TR201909626T4 (tr) 2019-07-22
US20150297592A1 (en) 2015-10-22
DK2869854T3 (da) 2019-07-22
ES2734252T3 (es) 2019-12-05
EP3153185A1 (de) 2017-04-12
DE102012013482A1 (de) 2014-01-09
CN107252427A (zh) 2017-10-17
EP3536351A1 (de) 2019-09-11
CN104540532A (zh) 2015-04-22
EP3153185B1 (de) 2020-03-25
WO2014009118A1 (de) 2014-01-16
US20170189435A1 (en) 2017-07-06
CN107252427B (zh) 2021-11-26
HUE044118T2 (hu) 2019-10-28
PT2869854T (pt) 2019-07-15
ES2800915T3 (es) 2021-01-05
US20210213039A1 (en) 2021-07-15

Similar Documents

Publication Publication Date Title
PT2869854T (pt) Composição contendo ectoína ou hidroxiectoína como substância ativa, para promover a regeneração de tecido corporal lesionado
GB2511713B (en) Compositions for the treatment of bone fragility
AP2014007533A0 (en) Substituted benzylindazoles for use as BUB1 kinaseinhibitors in the treatment of hyperproliferative diseases
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
PL2618768T3 (pl) Układ laserowy do traktowania tkanek ciała
HK1184370A1 (zh) 用於治療疼痛的藥物組合
HK1202458A1 (en) Glucokinase activator compositions for the treatment of diabetes
HK1182015A1 (zh) 活性藥物化合物用於治療中樞神經系統病症的用途
IL237568A0 (en) Assembly for the treatment of biological tissues
HK1215794A1 (zh) 用於治療疾病的同種異體自噬體富集組合物
HRP20181761T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
IL236823A0 (en) Preparations for use in the treatment of bone defects
HK1214771A1 (zh) 用於治療皮膚病的製劑
PT2456445E (pt) Agente para o tratamento de condições da pele
HUP1200552A2 (en) Pharmaceutical compositions for the treatment of high blood pressure
GB201010638D0 (en) Composition for treatment of skin
HK1210421A1 (en) Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3-
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds
GB201016836D0 (en) Composition for skin treatment